![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Prévisions du marché nord-américain des diagnostics moléculaires au point de service jusqu’en 2028 – Impact du COVID-19 et analyse régionale par produits et services (tests et kits, instruments, services et logiciels), technologie (PCR, technologie d’amplification des acides nucléiques isothermes (INAAT) et autres technologies), application (maladies infectieuses, oncologie, hématologie, tests prénatals, endocrinologie et autres applications), utilisateur final (hôpitaux et cliniques, laboratoires de diagnostic, instituts de recherche et universitaires et autres)
Introduction au marché
Les diagnostics moléculaires au point d\'intervention comprennent des appareils portables et des tests et ; kits utilisés pour détecter et diagnostiquer des maladies dans des échantillons humains, tels que des prélèvements de gorge, du sang, du sérum et des selles. Les diagnostics moléculaires passent des laboratoires centralisés aux tests moléculaires décentralisés sur les lieux d\'intervention. En raison de sa simplicité, de sa commodité, de son délai d\'exécution rapide et de son potentiel d\'amélioration des résultats pour les patients, le POCT gagne rapidement du terrain.
De plus, la demande croissante de méthodes de détection virale spécifiques qui consomment on s\'attend à ce que moins de temps pour contrôler les infections en temps opportun soutienne la croissance du marché au cours de la période de prévision.
Les États-Unis comptent le plus grand nombre de cas de COVID-19 de tous les pays d\'Amérique du Nord. Cela a eu un impact négatif sur diverses industries ainsi que sur les chaînes d’approvisionnement et de distribution de la région. Pendant la pandémie, les entreprises des sciences de la vie ont réorienté leurs efforts vers le développement de nouveaux médicaments pour le traitement de maladies potentiellement mortelles. En outre, la demande d’équipements de test rapide a également augmenté, ce qui joue un rôle de premier plan dans la croissance du marché nord-américain du diagnostic moléculaire au point d’intervention. De plus, la propagation continue du COVID-19 renforce la demande de kits de diagnostic moléculaire sur le lieu d’intervention. L’adoption de ces kits stimule le développement et le lancement de nouveaux produits. En mars 2021, Clinical Enterprise, Inc. d\'Eurofins a obtenu une autorisation d\'utilisation d\'urgence (EUA) de la Food and Drug Administration (FDA) des États-Unis pour une version destinée directement au consommateur (DTC) de son kit de collecte à domicile EmpowerDX COVID-19. De même, en juillet 2020, Clinical Diagnostics d\'Eurofins USA a annoncé la disponibilité de son test PCR groupé pour détecter le SRAS-CoV-2, ce qui réduirait considérablement le coût par test PCR pour les clients.
Aperçu et dynamique du marché
Le marché nord-américain du diagnostic moléculaire au point de service devrait atteindre 2 110,1 millions de dollars US d\'ici 2028, contre 860,9 millions de dollars US en 2021. Le marché devrait croître à un TCAC de 13,7 % entre 2021 et 2028. La pandémie actuelle de COVID-19 a également créé des opportunités pour les fabricants de kits de diagnostic moléculaire POC pour la détection du nouveau coronavirus. Par exemple, ABBOTT, un fabricant mondial d’équipements de santé et médicaux, a lancé ID NOW. Il s’agit d’un instrument moléculaire au point d’intervention permettant de détecter une nouvelle infection à coronavirus en moins de cinq minutes. ID NOW est une technique isotherme rapide, basée sur des instruments, pour détecter qualitativement les maladies infectieuses. Son produit exclusif d\'amplification isotherme des acides nucléiques et son produit exclusif d\'amplification isotherme des acides nucléiques. Les services génèrent des données moléculaires en quelques secondes, permettant aux médecins de prendre des décisions de traitement fondées sur des données probantes lors d\'une visite chez un patient. L\'ID NOW n\'a pas été certifié ou approuvé par la Food and Drug Administration (FDA). Il a été approuvé par la FDA pour une utilisation dans des laboratoires autorisés et des établissements de soins aux patients dans le cadre d\'une autorisation d\'utilisation d\'urgence (EUA). De telles innovations et développements de produits devraient offrir des opportunités lucratives pour la croissance du marché nord-américain du diagnostic moléculaire au point d’intervention au cours de la période de prévision.
Segments clés du marché
En termes de produits et de produits. services, le segment des tests et des kits représentait la plus grande part du marché nord-américain des diagnostics moléculaires au point de service en 2020. En termes de technologie, le segment PCR représentait la plus grande part du marché nord-américain des diagnostics moléculaires au point de service. Marché des diagnostics en 2020. En termes d’application, le segment des maladies infectieuses représentait la plus grande part du marché nord-américain des diagnostics moléculaires au point de service en 2020. En termes d’utilisateur final, le segment des laboratoires de diagnostic représentait la plus grande part de le marché nord-américain des diagnostics moléculaires au point de service en 2020.
Principales sources et sociétés répertoriées
Quelques sources primaires et secondaires majeures mentionnées pour la préparation de ce rapport sur le marché des diagnostics moléculaires au point de service en Amérique du Nord sont les sites Web des entreprises, les rapports annuels, les rapports financiers et les documents gouvernementaux nationaux. , et base de données statistiques, entre autres. Les principales sociétés répertoriées dans le rapport sont bioMérieux SA, F. Hoffmann-La Roche Ltd., Danaher Corporation, Enzo Biochem, Inc., Abbott, binx health, Inc., Meridian BioScience, Inc., Biocartis, Quidel Corporation et Bio-Rad Laboratories, Inc.
Rapport sur les raisons d\'acheter
- Comprendre le paysage du marché nord-américain du diagnostic moléculaire au point de service et identifier les segments de marché susceptibles de garantir un rendement élevé
- Pour comprendre le paysage du marché en constante évolution et garder une longueur d\'avance face à la concurrence
- Pour planifier efficacement les fusions et acquisitions et les accords de partenariat dans le Nord Marché américain du diagnostic moléculaire au point de service en identifiant les segments avec les ventes probables les plus prometteuses
- Prendre des décisions commerciales éclairées à partir d\'une analyse perspicace et complète des performances du marché de divers segments
- Pour obtenir les prévisions de revenus du marché nord-américain des diagnostics moléculaires au point de service, en fonction de divers segments pour la période 2021 à 2028
SEGMENTATION DU MARCHÉ DU DIAGNOSTIC MOLÉCULAIRE AU POINT DE SOINS EN AMÉRIQUE DU NORD
Par Produit et ; Services
- Tests et kits
- Instruments
- Services et logiciels
Par technologie
- PCR
- Technologie d\'amplification isotherme des acides nucléiques (INAAT)
- Autres technologies
Par Application
- Maladies infectieuses
- Oncologie
- Hématologie
- Tests prénatals
- Endocrinologie
- Autres applications
Par Utilisateur final
- Hôpitaux et cliniques
- Laboratoires de diagnostic
- Instituts de recherche et universitaires
- Autres
Par pays
- Amérique du Nord
- États-Unis
- Canada
- Mexique
Entreprises mentionnées
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
- binx health, Inc.
- Meridian BioScience, Inc.
- Biocartis
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Point-of-Care Molecular Diagnostics Market – By Product & Services
1.3.2 North America Point-of-Care Molecular Diagnostics Market – By Technology
1.3.3 North America Point-of-Care Molecular Diagnostics Market – By Application
1.3.4 North America Point-of-Care Molecular Diagnostics Market – By End User
1.3.5 North America Point-of-Care Molecular Diagnostics Market– By Geography
2. North America Point-of-Care Molecular Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Point-of-Care Molecular Diagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Experts Opinion
5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
5.1.2 Rising Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 Pricing Pressures owing to Reimbursement Cuts
5.3 Market Opportunities
5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics
5.4 Future Trends
5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting
5.5 Impact Analysis
6. Point-of-Care Molecular Diagnostics Market– North America Analysis
6.1 North America Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis
7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services
7.1 Overview
7.2 Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)
7.3 Assays and Kits
7.3.1 Overview
7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services and Software
7.5.1 Overview
7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology
8.1 Overview
8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)
8.3 PCR
8.3.1 Overview
8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Point-of-Care Molecular Diagnostics Market Analysis – By Application
9.1 Overview
9.2 Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Hematology
9.5.1 Overview
9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Prenatal Testing
9.6.1 Overview
9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Endocrinology
9.7.1 Overview
9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User
10.1 Overview
10.2 Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11. North America Point-of-Care Molecular Diagnostics Market – Geographic Analysis
11.1 North America: Point-of-Care Molecular Diagnostics Market
11.1.1 Overview
11.1.2 North America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 North America Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)
11.1.4 North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.5 North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.6 North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7 North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.2 US Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.4 US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.2 Canada Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.4 Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.2 Mexico Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.4 Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. Point-of-Care Molecular Diagnostics Market– Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 bioMérieux SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Abbott
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERIDIAN BIOSCIENCE, INC.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Enzo Biochem Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biocartis
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Quidel Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Danaher
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BIO-RAD LABORATORIES INC.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 binx health, inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. US Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)
Table 6. US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 7. US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Point-of-Care Molecular Diagnostics Market, by Product & services -Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Point-of-Care Molecular Diagnostics Market, by Product & services -Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market
Table 18. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market
Table 19. Glossary of Terms, Point-of-Care Molecular Diagnostics Market
LIST OF FIGURES
Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation
Figure 2. North America Point-of-Care Molecular Diagnostics Market Overview
Figure 3. Assays and Kits Segment Held the Largest Share by Product & services in North America Point-of-Care Molecular Diagnostics Market
Figure 4. US to Show Significant Growth During Forecast Period
Figure 5. North America Point-of-Care Molecular Diagnostics Market, Industry Landscape
Figure 6. North America PEST Analysis
Figure 7. North America Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 8. Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)
Figure 9. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)
Figure 13. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)
Figure 17. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)
Figure 24. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 29. North America Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 30. North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 31. US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in North America
Figure 35. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
- binx health, Inc.
- Meridian BioScience, Inc.
- Biocartis
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Point-of-Care molecular diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.